Overview

A Randomized Comparison of CLOpidogrel Monotherapy Versus Extended Dual-antiplatelet Therapy Beyond 12 Months After Implantation of Drug-eluting StEnts in High-risk Lesions or Patients; A-CLOSE Trial

Status:
Recruiting

Trial end date:
2023-04-01

Target enrollment:

Participant gender:

Summary

The investigators hypothesized that clopidogrel mono-therapy will not be inferior to the extended DAPT in terms of the occurrence of both ischemic and bleeding events, for lesions or patients at high risk for either ischemic or bleeding complications 12 months after drug-eluting stent (DES) implantation.

Phase:

Phase 4

Details

Lead Sponsor:

Yonsei University

Treatments:

Aspirin
Clopidogrel